126 related articles for article (PubMed ID: 8737597)
21. A pathological study of the association between Lewy body disease and Alzheimer's disease.
Gibb WR; Mountjoy CQ; Mann DM; Lees AJ
J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):701-8. PubMed ID: 2545826
[TBL] [Abstract][Full Text] [Related]
22. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
23. MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease.
Almeida OP; Burton EJ; McKeith I; Gholkar A; Burn D; O'Brien JT
Dement Geriatr Cogn Disord; 2003; 16(2):57-63. PubMed ID: 12784028
[TBL] [Abstract][Full Text] [Related]
24. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
[TBL] [Abstract][Full Text] [Related]
25. Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases.
Gnanalingham KK; Byrne EJ; Thornton A; Sambrook MA; Bannister P
J Neurol Neurosurg Psychiatry; 1997 Mar; 62(3):243-52. PubMed ID: 9069479
[TBL] [Abstract][Full Text] [Related]
26. Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology.
Lippa CF; Smith TW; Perry E
J Neural Transm (Vienna); 1999; 106(5-6):525-35. PubMed ID: 10443555
[TBL] [Abstract][Full Text] [Related]
27. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
Beyer MK; Larsen JP; Aarsland D
Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
[TBL] [Abstract][Full Text] [Related]
28. Pathological α-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology.
Toledo JB; Gopal P; Raible K; Irwin DJ; Brettschneider J; Sedor S; Waits K; Boluda S; Grossman M; Van Deerlin VM; Lee EB; Arnold SE; Duda JE; Hurtig H; Lee VM; Adler CH; Beach TG; Trojanowski JQ
Acta Neuropathol; 2016 Mar; 131(3):393-409. PubMed ID: 26721587
[TBL] [Abstract][Full Text] [Related]
29. Lewy bodies in the lateral hypothalamus: do they imply neuronal loss?
Kremer HP; Bots GT
Mov Disord; 1993 Jul; 8(3):315-20. PubMed ID: 8341295
[TBL] [Abstract][Full Text] [Related]
30. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.
Bayer TA; Jäkälä P; Hartmann T; Havas L; McLean C; Culvenor JG; Li QX; Masters CL; Falkai P; Beyreuther K
Neurosci Lett; 1999 May; 266(3):213-6. PubMed ID: 10465711
[TBL] [Abstract][Full Text] [Related]
31. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
[TBL] [Abstract][Full Text] [Related]
32. Acetylcholinesterase in Huntington's and Alzheimer's diseases: simultaneous enzyme assay and immunoassay of multiple brain regions.
Hammond P; Brimijoin S
J Neurochem; 1988 Apr; 50(4):1111-6. PubMed ID: 2964509
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical localization of X-linked inhibitor of apoptosis protein in brainstem-type and cortical Lewy bodies.
Kawamoto Y; Ito H; Ihara M; Takahashi R
Neuroreport; 2012 Feb; 23(3):162-7. PubMed ID: 22273571
[TBL] [Abstract][Full Text] [Related]
34. Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.
Chiasserini D; Biscetti L; Eusebi P; Salvadori N; Frattini G; Simoni S; De Roeck N; Tambasco N; Stoops E; Vanderstichele H; Engelborghs S; Mollenhauer B; Calabresi P; Parnetti L
Alzheimers Res Ther; 2017 Jul; 9(1):52. PubMed ID: 28750675
[TBL] [Abstract][Full Text] [Related]
35. Lewy body diseases with dementia: pathophysiology and treatment.
Cummings JL
Brain Cogn; 1995 Aug; 28(3):266-80. PubMed ID: 8546854
[TBL] [Abstract][Full Text] [Related]
36. BACE1 mRNA expression in Alzheimer's disease postmortem brain tissue.
Coulson DT; Beyer N; Quinn JG; Brockbank S; Hellemans J; Irvine GB; Ravid R; Johnston JA
J Alzheimers Dis; 2010; 22(4):1111-22. PubMed ID: 20930286
[TBL] [Abstract][Full Text] [Related]
37. Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography.
Koeppe RA; Gilman S; Junck L; Wernette K; Frey KA
Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S67-76. PubMed ID: 18632004
[TBL] [Abstract][Full Text] [Related]
38. Amyloid beta-peptide and the dementia of Parkinson's disease.
Jendroska K; Lees AJ; Poewe W; Daniel SE
Mov Disord; 1996 Nov; 11(6):647-53. PubMed ID: 8914090
[TBL] [Abstract][Full Text] [Related]
39. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.
Perry EK; Curtis M; Dick DJ; Candy JM; Atack JR; Bloxham CA; Blessed G; Fairbairn A; Tomlinson BE; Perry RH
J Neurol Neurosurg Psychiatry; 1985 May; 48(5):413-21. PubMed ID: 3998751
[TBL] [Abstract][Full Text] [Related]
40. Accumulation of NACP/alpha-synuclein in lewy body disease and multiple system atrophy.
Shoji M; Harigaya Y; Sasaki A; Uéda K; Ishiguro K; Matsubara E; Watanabe M; Ikeda M; Kanai M; Tomidokoro Y; Shizuka M; Amari M; Kosaka K; Nakazato Y; Okamoto K; Hirai S
J Neurol Neurosurg Psychiatry; 2000 May; 68(5):605-8. PubMed ID: 10766891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
